We are international
• treatment options TEXT SIZE   
novel therapies    back

ASH 2011: Dr. Jakubowiak - Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)
Andrzej J Jakubowiak, MD, PhD
University of Michigan
Ann Arbor, Michigan, USA

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles